Annual CFI
$4000.00
-$8.30 M-99.95%
December 31, 2023
Summary
- As of March 10, 2025, RDHL annual cash flow from investing activities is $4000.00, with the most recent change of -$8.30 million (-99.95%) on December 31, 2023.
- During the last 3 years, RDHL annual CFI has risen by +$35.65 million (+100.01%).
- RDHL annual CFI is now -99.98% below its all-time high of $24.47 million, reached on December 31, 2016.
Performance
RDHL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
June 1, 2024
Summary
- RDHL quarterly cash flow from investing activities is not available.
Performance
RDHL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
June 1, 2024
Summary
- RDHL TTM cash flow from investing activities is not available.
Performance
RDHL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RDHL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | +100.0% | - | - |
| 5 y5 years | -99.9% | - | - |
RDHL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | +100.0% | ||||
| 5 y | 5-year | -100.0% | +100.0% | ||||
| alltime | all time | -100.0% | +100.0% |
RedHill Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $4000.00(-100.0%) | - | - |
| Jun 2023 | - | -$7000.00(<-9900.0%) | -$29.00 K(-84.3%) |
| Mar 2023 | - | $0.00(0.0%) | -$185.00 K(-102.2%) |
| Dec 2022 | $8.30 M(-202.0%) | $0.00(-100.0%) | $8.30 M(-29.6%) |
| Sep 2022 | - | -$22.00 K(-86.5%) | $11.80 M(+257.5%) |
| Jun 2022 | - | -$163.00 K(-101.9%) | $3.30 M(-8350.0%) |
| Mar 2022 | - | $8.49 M(+142.7%) | -$40.00 K(-99.5%) |
| Dec 2021 | -$8.14 M(-77.2%) | $3.50 M(-141.0%) | -$8.14 M(+115.0%) |
| Sep 2021 | - | -$8.52 M(+143.2%) | -$3.79 M(-164.1%) |
| Jun 2021 | - | -$3.50 M(-1005.2%) | $5.91 M(-115.1%) |
| Mar 2021 | - | $387.00 K(-95.1%) | -$39.26 M(+10.1%) |
| Dec 2020 | -$35.65 M(-790.3%) | $7.85 M(+568.7%) | -$35.65 M(-26.3%) |
| Sep 2020 | - | $1.17 M(-102.4%) | -$48.40 M(+27.9%) |
| Jun 2020 | - | -$48.67 M(-1316.8%) | -$37.83 M(-607.7%) |
| Mar 2020 | - | $4.00 M(-181.7%) | $7.45 M(+44.3%) |
| Dec 2019 | $5.16 M(-3.5%) | -$4.90 M(-141.7%) | $5.16 M(-49.5%) |
| Sep 2019 | - | $11.74 M(-446.3%) | $10.23 M(-389.0%) |
| Jun 2019 | - | -$3.39 M(-298.0%) | -$3.54 M(-156.2%) |
| Mar 2019 | - | $1.71 M(+878.3%) | $6.30 M(+17.8%) |
| Dec 2018 | $5.35 M(-128.8%) | $175.00 K(-108.6%) | $5.35 M(-238.9%) |
| Sep 2018 | - | -$2.04 M(-131.6%) | -$3.85 M(-131.8%) |
| Jun 2018 | - | $6.46 M(+749.5%) | $12.10 M(+1461.5%) |
| Mar 2018 | - | $760.00 K(-108.4%) | $775.00 K(-104.2%) |
| Dec 2017 | -$18.58 M | -$9.03 M(-164.9%) | -$18.58 M(-258.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $13.91 M(-385.7%) | $11.76 M(+37.9%) |
| Jun 2017 | - | -$4.87 M(-73.8%) | $8.53 M(-18.6%) |
| Mar 2017 | - | -$18.60 M(-187.2%) | $10.48 M(-57.2%) |
| Dec 2016 | $24.47 M(-215.5%) | $21.32 M(+99.5%) | $24.47 M(-244.8%) |
| Sep 2016 | - | $10.68 M(-465.3%) | -$16.90 M(-32.8%) |
| Jun 2016 | - | -$2.92 M(-36.4%) | -$25.14 M(+34.3%) |
| Mar 2016 | - | -$4.60 M(-77.1%) | -$18.72 M(-11.7%) |
| Dec 2015 | -$21.19 M(+18.6%) | -$20.06 M(-919.1%) | -$21.19 M(+1689.9%) |
| Sep 2015 | - | $2.45 M(-29.9%) | -$1.18 M(-74.6%) |
| Jun 2015 | - | $3.50 M(-149.4%) | -$4.66 M(-81.3%) |
| Mar 2015 | - | -$7.08 M(>+9900.0%) | -$24.91 M(+39.5%) |
| Dec 2014 | -$17.86 M(-1682.1%) | -$51.00 K(-95.0%) | -$17.86 M(+1.8%) |
| Sep 2014 | - | -$1.02 M(-93.9%) | -$17.54 M(+4.9%) |
| Jun 2014 | - | -$16.76 M(>+9900.0%) | -$16.72 M(-3117.7%) |
| Mar 2014 | - | -$25.00 K(-109.2%) | $554.00 K(-50.9%) |
| Dec 2013 | $1.13 M(-62.1%) | $272.00 K(-234.0%) | $1.13 M(-66.9%) |
| Sep 2013 | - | -$203.00 K(-139.8%) | $3.41 M(-64.5%) |
| Jun 2013 | - | $510.00 K(-7.3%) | $9.61 M(+6.8%) |
| Mar 2013 | - | $550.00 K(-78.5%) | $9.00 M(+202.3%) |
| Dec 2012 | $2.98 M(-162.5%) | $2.56 M(-57.4%) | $2.98 M(+605.5%) |
| Sep 2012 | - | $5.99 M(-6094.0%) | $422.00 K(-107.6%) |
| Jun 2012 | - | -$100.00 K(-98.2%) | -$5.57 M(+1.8%) |
| Mar 2012 | - | -$5.47 M | -$5.47 M |
| Dec 2011 | -$4.77 M(+369.2%) | - | - |
| Dec 2010 | -$1.02 M | - | - |
FAQ
- What is RedHill Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for RedHill Biopharma?
- What is RedHill Biopharma annual CFI year-on-year change?
- What is the all time high quarterly CFI for RedHill Biopharma?
- What is the all time high TTM CFI for RedHill Biopharma?
What is RedHill Biopharma annual cash flow from investing activities?
The current annual CFI of RDHL is $4000.00
What is the all time high annual CFI for RedHill Biopharma?
RedHill Biopharma all-time high annual cash flow from investing activities is $24.47 M
What is RedHill Biopharma annual CFI year-on-year change?
Over the past year, RDHL annual cash flow from investing activities has changed by -$8.30 M (-99.95%)
What is the all time high quarterly CFI for RedHill Biopharma?
RedHill Biopharma all-time high quarterly cash flow from investing activities is $21.32 M
What is the all time high TTM CFI for RedHill Biopharma?
RedHill Biopharma all-time high TTM cash flow from investing activities is $24.47 M